BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 6318004)

  • 21. Effect of chlorphentermine on the lipids of rat lungs.
    Gloster J; Heath D; Hasleton P; Harris P
    Thorax; 1976 Oct; 31(5):558-64. PubMed ID: 996817
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery from chlorphentermine-induced phospholipidosis in rat alveolar macrophages: morphological features.
    Reasor MJ; Walker ER
    Exp Mol Pathol; 1981 Dec; 35(3):370-9. PubMed ID: 7308413
    [No Abstract]   [Full Text] [Related]  

  • 23. Increased lysosomal enzyme activities in tissues of rats suffering from chlorphentermine induced lipidosis.
    Lüllmann H; Mösinger EU
    Biochem Pharmacol; 1979 Apr; 28(7):1015-6. PubMed ID: 109091
    [No Abstract]   [Full Text] [Related]  

  • 24. [Morphologic and histochemical studies of the development of chloroquine-induced storage disease in the semilunar ganglion of the rat].
    Dietzmann K; Kemnitz P; Schneidewind J
    Acta Histochem; 1985; 76(1):37-47. PubMed ID: 3925698
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chlorphentermine-induced alterations in the lungs of vitamin E-deficient and supplemented rats: 1. Biochemical and morphometric analysis of the pulmonary response.
    Gairola C; Matulionis DH; Reasor MJ
    Exp Mol Pathol; 1983 Jun; 38(3):368-79. PubMed ID: 6852209
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. I. Drug and phospholipid levels.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):55-9. PubMed ID: 3941400
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lipidosis-like alterations in hypothalamic neurosecretory cells of rats treated with chlorphentermine or iprindole.
    Lüllmann-Rauch R
    Cell Tissue Res; 1974 Jun; 149(4):587-90. PubMed ID: 4367860
    [No Abstract]   [Full Text] [Related]  

  • 28. Role of the alveolar macrophage in the induction of pulmonary phospholipidosis by chlorphentermine. II. Drug uptake into cells in vitro.
    Heyneman CA; Reasor MJ
    J Pharmacol Exp Ther; 1986 Jan; 236(1):60-4. PubMed ID: 3941401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytochemical demonstration of increased phospholipid content in cell membranes in chlorphentermine-induced phospholipidosis.
    Coulombe PA; Bendayan M
    J Histochem Cytochem; 1989 Feb; 37(2):139-47. PubMed ID: 2911004
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cationic amphiphilic drug-induced renal cortical lysosomal phospholipidosis: an in vivo comparative study with gentamicin and chlorphentermine.
    Kacew S
    Toxicol Appl Pharmacol; 1987 Dec; 91(3):469-76. PubMed ID: 3424375
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Chloroquine keratopathy as an example of drug-induced phospholipidosis (contribution to the pathogenesis of cornea verticillata) (author's transl)].
    Seiler KU; Thiel HJ; Wassermann O
    Klin Monbl Augenheilkd; 1977 Jan; 170(1):64-73. PubMed ID: 15159
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Phospholipidosis in the alveolar macrophage induced by cationic amphiphilic drugs.
    Reasor MJ
    Fed Proc; 1984 Aug; 43(11):2578-81. PubMed ID: 6745447
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Palmitic acid-1-14C incorporation and turnover in lung phospholipids of rats treated with chlorphentermine, RMI 10.393 and Ro 4-4318.
    Karabelnik D; Zbinden G
    Arch Toxicol; 1976 Jun; 35(3):163-74. PubMed ID: 989288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chlorphentermine-induced changes of the peripheral vestibular sense organ of the rat.
    Bichler E; Anniko M
    Acta Otolaryngol; 1983; 96(5-6):421-8. PubMed ID: 6138918
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipidosis-like cellular alterations in lymphatic tissues of chlorphentermine-treated animals.
    Lüllmann-Rauch R; Pietschmann N
    Virchows Arch B Cell Pathol; 1974; 15(4):295-308. PubMed ID: 4367544
    [No Abstract]   [Full Text] [Related]  

  • 36. Morphological and functional changes in mouse splenic lymphocytes following in vivo and in vitro exposure to chlorphentermine.
    Sauers LJ; Wierda D; Walker ER; Reasor MJ
    J Immunopharmacol; 1986; 8(4):611-31. PubMed ID: 3027187
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of chlorphentermine-induced pulmonary phospholipidosis in rats by phenobarbital.
    Reasor MJ; Davis ME
    Drug Metab Dispos; 1985; 13(2):192-6. PubMed ID: 2859167
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug-induced phospholipidosis.
    Lüllmann H; Lüllmann-Rauch R; Wassermann O
    Ger Med; 1973; 3(3-4):128-35. PubMed ID: 4370610
    [No Abstract]   [Full Text] [Related]  

  • 39. In vivo and in vitro reversibility of chlorphentermine-induced phospholipidosis in rat alveolar macrophages.
    McCloud CM; Beard TL; Kacew S; Reasor MJ
    Exp Mol Pathol; 1995 Feb; 62(1):12-21. PubMed ID: 7556587
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in peripheral nerves of rats treated with chlorphentermine or with iprindole.
    Drenckhahn D; Lüllmann-Rauch R
    Cell Tissue Res; 1976 Aug; 171(2):273-6. PubMed ID: 184953
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.